Granulocyte Macrophage Colony Stimulating Factor Market Report

Global and China Granulocyte Macrophage Colony Stimulating Factor Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 29, 2022
  • PAGES：203
  • REPORT CODE：GMM1418825
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Granulocyte Macrophage Colony Stimulating Factor industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Cold Genesys Inc

    • BriaCell Therapeutics Corp

    • Takeda Pharmaceutical Co Ltd

    • Aduro BioTech Inc

    • Morphotek Inc

    • GlaxoSmithKline Plc

    • Amgen Inc

    • Humanigen Inc

    • Sillajen Biotherapeutics

    • Mologen AG

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • CG-0070

    • Gimsilumab

    • GSK-3196165

    • Lenzilumab

    • MGN-1601

    • Others

    Application:

    • Solid Tumor

    • Lymphoma

    • Kidney Cancer

    • Lung Disease

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Granulocyte Macrophage Colony Stimulating Factor Industry Overview

      • 1.1.1 Granulocyte Macrophage Colony Stimulating Factor Market Scope and Market Segments

      • 1.1.2 Granulocyte Macrophage Colony Stimulating Factor Industry Characteristics

      • 1.1.3 Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Granulocyte Macrophage Colony Stimulating Factor Production Value and Growth Rate (2017-2028)

    • 1.2 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 CG-0070

      • 1.2.2 Gimsilumab

      • 1.2.3 GSK-3196165

      • 1.2.4 Lenzilumab

      • 1.2.5 MGN-1601

      • 1.2.6 Others

    • 1.3 Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Solid Tumor

      • 1.3.2 Lymphoma

      • 1.3.3 Kidney Cancer

      • 1.3.4 Lung Disease

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Granulocyte Macrophage Colony Stimulating Factor Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Granulocyte Macrophage Colony Stimulating Factor Industry Porter's Five Forces Model Analysis

      • 2.2.3 Granulocyte Macrophage Colony Stimulating Factor Industry PEST Analysis

    • 2.3 Granulocyte Macrophage Colony Stimulating Factor Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Granulocyte Macrophage Colony Stimulating Factor Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Granulocyte Macrophage Colony Stimulating Factor Industry

    Chapter 3 Global and China Granulocyte Macrophage Colony Stimulating Factor Market, by Manufacturer

    • 3.1 Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Granulocyte Macrophage Colony Stimulating Factor Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Granulocyte Macrophage Colony Stimulating Factor Market Top 3 Players

    Chapter 4 Global and China Granulocyte Macrophage Colony Stimulating Factor Market, by Type (2017-2028)

    • 4.1 Granulocyte Macrophage Colony Stimulating Factor Market Trend, by Type

    • 4.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor Price Trend, by Type (2017-2028)

    • 4.3 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Granulocyte Macrophage Colony Stimulating Factor Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Granulocyte Macrophage Colony Stimulating Factor Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Granulocyte Macrophage Colony Stimulating Factor Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Granulocyte Macrophage Colony Stimulating Factor Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Granulocyte Macrophage Colony Stimulating Factor Market Analysis

    • 7.1 North America Granulocyte Macrophage Colony Stimulating Factor Market, by Type

    • 7.2 North America Granulocyte Macrophage Colony Stimulating Factor Market, by Application

    • 7.3 North America Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast, by Country

      • 7.3.1 United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Granulocyte Macrophage Colony Stimulating Factor Market Analysis

    • 8.1 Europe Granulocyte Macrophage Colony Stimulating Factor Market, by Type

    • 8.2 Europe Granulocyte Macrophage Colony Stimulating Factor Market, by Application

    • 8.3 Europe Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast, by Country

      • 8.3.1 Germany Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Granulocyte Macrophage Colony Stimulating Factor Market Analysis

    • 9.1 APAC Granulocyte Macrophage Colony Stimulating Factor Market, by Type

    • 9.2 APAC Granulocyte Macrophage Colony Stimulating Factor Market, by Application

    • 9.3 APAC Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast, by Country

      • 9.3.1 China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Analysis

    • 10.1 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market, by Type

    • 10.2 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market, by Application

    • 10.3 Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Granulocyte Macrophage Colony Stimulating Factor Company Profiles

      • 11.1 Cold Genesys Inc

        • 11.1.1 Cold Genesys Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.1.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 BriaCell Therapeutics Corp

        • 11.2.1 BriaCell Therapeutics Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.2.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Takeda Pharmaceutical Co Ltd

        • 11.3.1 Takeda Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.3.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Aduro BioTech Inc

        • 11.4.1 Aduro BioTech Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.4.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Morphotek Inc

        • 11.5.1 Morphotek Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.5.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 GlaxoSmithKline Plc

        • 11.6.1 GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.6.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Amgen Inc

        • 11.7.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.7.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Humanigen Inc

        • 11.8.1 Humanigen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.8.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sillajen Biotherapeutics

        • 11.9.1 Sillajen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Mologen AG

        • 11.10.1 Mologen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Profiles, Application and Specification

        • 11.10.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Granulocyte Macrophage Colony Stimulating Factor Industry Investment Prospect and Risk Assessment

    • 12.1 Granulocyte Macrophage Colony Stimulating Factor Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Granulocyte Macrophage Colony Stimulating Factor Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Production Value and Growth Rate (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Production Value and Growth Rate (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of CG-0070 (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Gimsilumab (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of GSK-3196165 (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lenzilumab (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of MGN-1601 (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Solid Tumor (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lymphoma (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Kidney Cancer (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Lung Disease (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Granulocyte Macrophage Colony Stimulating Factor Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Granulocyte Macrophage Colony Stimulating Factor Market Share, by Manufacturer in 2021

    • Figure Global and China Granulocyte Macrophage Colony Stimulating Factor Market Share, by Manufacturer in 2022

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Type (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Type (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Price Trend, by Type (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Type (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Type (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Price Trend, by Type (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Application (2017-2028)

    • Table Global Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Application (2017-2028)

    • Figure Global Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Application (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Value, by Application (2017-2028)

    • Table China Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Application (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Value Share, by Application (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Production, Import, Consumption and Export (2017-2022)

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure North America Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure United States Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Canada Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure Europe Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure Germany Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure UK Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure UK Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure France Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure France Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Italy Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Spain Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Poland Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Russia Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Table APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure APAC Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure China Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure India Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Granulocyte Macrophage Colony Stimulating Factor Sales Value and Growth Rate (2017-2028)

    • Table Cold Genesys Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cold Genesys Inc Product Profiles, Application and Specification

    • Table Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BriaCell Therapeutics Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BriaCell Therapeutics Corp Product Profiles, Application and Specification

    • Table BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Co Ltd Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Aduro BioTech Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Aduro BioTech Inc Product Profiles, Application and Specification

    • Table Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Morphotek Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Morphotek Inc Product Profiles, Application and Specification

    • Table Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Inc Product Profiles, Application and Specification

    • Table Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Humanigen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Humanigen Inc Product Profiles, Application and Specification

    • Table Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sillajen Biotherapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sillajen Biotherapeutics Product Profiles, Application and Specification

    • Table Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mologen AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mologen AG Product Profiles, Application and Specification

    • Table Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US